Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Distinct and Atypical Intrinsic and Extrinsic Cell Death Pathways between Photoreceptor Cell Types upon Specific Ablation of Ranbp2 in Cone Photoreceptors.
Differential aspects of immune cell infiltration and neurodegeneration in acute and relapse experimental autoimmune encephalomyelitis.
T lymphocyte proliferation is suppressed by the opioid growth factor ([Met(5)]-enkephalin)-opioid growth factor receptor axis: implication for the treatment of autoimmune diseases.
Neurologic indications for therapeutic plasma exchange: 2013 update.
[Driving ability with multiple sclerosis.]
Intestinal barrier dysfunction develops at the onset of experimental autoimmune encephalomyelitis, and can be induced by adoptive transfer of auto-reactive T cells.
[Regarding the article: "multiple sclerosis treatment with natalizumab: analysis of a hospital-based cohort"].
Fatigue in multiple sclerosis: The contribution of occult white matter damage.
Targeting of ECM molecules and their metabolizing enzymes and receptors for the treatment of CNS diseases.
Experimental models of neuromyelitis optica: current status, challenges and future directions.
Immunization with a peptide of Semliki Forest virus promotes remyelination in experimental autoimmune encephalomyelitis.
Environmental risk factors for multiple sclerosis: a review with a focus on molecular mechanisms.
Sleep disturbances in patients with multiple sclerosis.
Understanding hope in patients with Multiple Sclerosis.
Ipsilateral uveitis and optic neuritis in multiple sclerosis.
Employment and Community Living Issues for People with Multiple Sclerosis.
Experimental autoimmune encephalomyelitis is a good model of multiple sclerosis if used wisely.
Visual Evoked Potential Recording in a Rat Model of Experimental Optic Nerve Demyelination.
Use of a physiological profile to document motor impairment in ageing and in clinical groups.
Identification of Inflammatory Neuronal Injury and Prevention of Neuronal Damage in Multiple Sclerosis: Hope for Novel Therapies?
An MR Brain Images Classifier System via Particle Swarm Optimization and Kernel Support Vector Machine.
Fully automated open-source lesion mapping of T2-FLAIR images with FSL correlates with clinical disability in MS.
Cannabinoids: Medical implications.
Treatment of optic neuritis with erythropoietin (TONE): a randomised, double-blind, placebo-controlled trial-study protocol.
The potential role of pharmacogenomics in the prevention of serious adverse drug reactions in multiple sclerosis.
Pages
« first
‹ previous
…
459
460
461
462
463
464
465
466
467
…
next ›
last »